Hematology TimesFDA approves drug for patients receiving MECFebruary 5, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesGeneric imatinib launched with savings programFebruary 4, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLMyelodysplastic Syndrome
Hematology TimesEHA creates ‘roadmap’ for hematology researchFebruary 3, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisBlood Banking
Hematology TimesHealth Canada approves drug for multiple myelomaJanuary 29, 2016Multiple MyelomaPharmacy
Hematology TimesDrug nets 3rd breakthrough designation from FDAJanuary 29, 2016Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesNICE recommends panobinostat for multiple myelomaJanuary 28, 2016Multiple MyelomaPharmacy
Hematology TimesDrug granted another breakthrough designation for CLLJanuary 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug approved to treat ALL in EUJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology TimesFDA approves maintenance therapy for CLLJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
